Semaglutide

A drug used for treating diabetes has been recommended by the National Institute for Health and Care Excellence (NICE) to treat thousands of people with obesity ...

Log in through your institution Log in It is injected once a week by patients.

Weight-loss jab WeGovy, which is loved by celebs, may not actually be a miracle fix, as experts warn users will likely pile back on the pounds after they ...

They regained two-thirds of that weight, or 12% of their original body weight in the year after dropping the weekly injections. Top Gear host Jeremy Clarkson (left) revealed he was taking Ozempic, a brand of semaglutide, in a bid to lose weight. Elon Musk (left) credits his spectacular weight loss in 2020 to Wegovy. The mother-of-four said: 'If you’re looking for a sign to start Wegovy/Ozempic, HERE IT IS!' TikTok star Remi Bader (right) revealed that she was prescribed Ozempic by her doctor in 2020 'before it was trendy' It remains to be seen how the emergence of this new class of drugs can be used to meet this challenge.' The drug is very effective when you are taking it, and so far, has been shown to take for several months. Ciara Lawless, 40, from Dublin, lost 2st (28lbs/12.7kg) in May 2020 after getting semaglutide injections when she weighed around 12 and a half stone. 'Semaglutide should be available to anyone who needs it.' Private clinics in the UK have given clients Ozempic off-label for just under £200 per month. [ 'Game-changing' weight loss jab Wegovy will be rolled out on NHS in weeks... so will YOU be eligible to get Hollywood's 'worst-kept secret'?

The weight loss injection, also known by brand name Ozempic, is rumoured to be used by Hollywood A-listers to drop weight, but it has sparked controversy.

Doctors have emphasised that patients must make dietary and lifestyle changes to lose weight alongside using the drug, and it is not a miracle cure. It is delivered using a weekly injection for a maximum of two years. ['My phobia of ketchup is so bad I cry if I see it and have to leave the room if someone is eating it'](https://www.mylondon.news/news/health/my-phobia-ketchup-bad-cry-26399741)

A drug which suppresses appetite will soon be available through the NHS. Semaglutide, also known as Wegovy, has been hailed a “game changer” and is ...

Novo Nordisk said in a statement that it was working to get the drug to the UK “as soon as possible”. In some cases, people with a BMI of 30 and over may be able to access the drug. It is to be used alongside a reduced-calorie diet and increased physical activity, Nice said. The list price of semaglutide 0.25mg, 0.5mg and 1mg is £73.25 per pack (four pre-filled pens excluding VAT). Eating disorder charity Beat raised concerns about the drug. ['I thought my stomach pains were just constipation... A previous study found that people who are given the drug saw their weight drop by 12 per cent on average after 68 weeks. The weight-related conditions that make obese people eligible include type 2 diabetes, prediabetes, high blood pressure, dyslipidaemia (unbalanced or unhealthy cholesterol levels), obstructive sleep apnoea and heart disease. The drug, manufactured by Danish firm Novo Nordisk, is an appetite suppressant which is delivered via a weekly injection. The drug will also be available to buy privately and a number of UK pharmacies have already said they will offer the drug once it becomes available. So when exactly will the drug be available on the NHS, who will be eligible for it and what have the experts said? Thousands of people will be eligible when the drug becomes available on the NHS.

Thousands of people living with obesity in England are expected to be offered the appetite suppressant Wegovy on prescription after the National Institute for ...

We are working to make Wegovy available in the UK as soon as possible.” The NHS in England is required to implement the Nice recommendations within three months of the product becoming commercially available. Tom Quinn, Beat’s director of external affairs, said: “Weight-loss medications like semaglutide can be extremely attractive to people with eating disorders as they appear to provide quick results. We are pleased to finally publish our final guidance on semaglutide which will mean some people will be able to access this much talked about drug on the NHS.” The drug is to be used alongside a reduced-calorie diet and increased physical activity, Nice said. Wegovy, also known as semaglutide, has been used by the likes of Billionaire Elon Musk to keep in shape.

Health officials have announced that some people will be offered the appetite suppressant Wegovy on prescription, after approval was given for NHS use.

Commenting on the news, Alex Miras, professor of endocrinology at Ulster University, said: "This decision made by Nice is a pivotal moment for the treatment of people living with obesity. Dr Stephen Lawrence, associate clinical professor at the University of Warwick, added: "When used in accordance with the prescribed guidelines, it promotes weight loss in a safe and effective way for most people. Our committee has made specific recommendations to ensure it remains value for money for the taxpayer, and it can only be used for a maximum of two years. The drug will be available to NHS patients soon when the launch of the drug in England is confirmed by manufacturer Novo Nordisk. The NHS in England is required to implement the NICE recommendations within three months of the product becoming commercially available. It is to be used alongside a reduced-calorie diet and increased physical activity, NICE said.

Thousands of obese people in England could soon follow celebrities such as Elon Musk in taking the drug.

“It won’t be available to everyone. The injectable is already available privately through pharmacists and costs on average £130 per month. The drug will be available to NHS patients soon when the launch of the drug in England is confirmed by manufacturer Novo Nordisk. [Elon Musk](https://www.standard.co.uk/topic/elon-musk) have [claimed to have used the drug](https://www.standard.co.uk/news/health/wegovy-weight-loss-drug-available-nhs-elon-musk-kim-kardashian-b1065543.html). Mild nausea, diarrhoea and headaches are some of the side effects but they were found to be “mild to moderate in severity and subsided with time”. [National Institute for Health and Care Excellence](/topic/national-institute-for-health-and-care-excellence) (Nice) gave it the green light.

A weight loss jab have been approved for use through the NHS for people with at least one weight-related condition and a BMI score of at least 35.

[weight loss jab](https://www.mirror.co.uk/news/health/wegovy-weight-loss-jab-sold-29232964) after it gained popularity in the US - but experts have warned that it could be a “gateway to eating disorders”. “It won’t be available to everyone. [gateway for eating disorders](https://www.mirror.co.uk/news/health/wegovy-weight-loss-jab-sold-29232964)' while it has the potential to make things worse for those already struggling with disordered eating. [body mass index](https://www.mirror.co.uk/news/health/how-calculate-your-body-mass-12424551) (BMI) score of at least 35, while those with a score of 30 and over may also be able to access it in some cases. Our committee has made specific recommendations to ensure it remains value for money for the taxpayer, and it can only be used for a maximum of two years. [Elon Musk](https://www.mirror.co.uk/all-about/elon-musk) claim to have used the drug, with many in Hollywood referring to it as “the skinny shot”. [diabetes medicine Ozempic](https://www.mirror.co.uk/news/uk-news/tiktok-diet-sparks-concerns-over-29251149), which is prescribed to patients with type 2 diabetes - whereas Wegovy is recommended specifically for weight loss. [MedlinePlus](https://medlineplus.gov/druginfo/meds/a618008.html#:~:text=Semaglutide%20injection%20is%20in%20a,it%20is%20used%20for%20energy.), Wegovy is used alongside an individualised low-calorie, low-fat diet and exercise program to help with weight loss in obese or overweight adults who may also have high [blood pressure](https://www.mirror.co.uk/lifestyle/health/ten-ways-banish-high-blood-9621402), diabetes, or high cholesterol. [healthy eating and exercise](https://www.mirror.co.uk/all-about/healthy-living), and can only be offered to those who hit a certain criteria. [blood sugar levels](https://www.mirror.co.uk/news/health/blood-sugar-levels-7-foods-27650387) are high. [Prescription drug Wegovy](https://www.mirror.co.uk/news/uk-news/brits-game-changing-weight-loss-26170776), also known as Semaglutide, has been labelled safe, effective and affordable by the National Institute for Health and Care Excellence ( [NICE](https://www.nice.org.uk/)). [NHS](https://www.mirror.co.uk/all-about/nhs) in England will inject themselves weekly using a pen and the drug works by making people feel fuller and more satisfied, so they eat less.

The weight-loss drug semaglutide – also known as Wegovy – could soon be available for prescription via specialist NHS services.

NICE said semaglutide will be available to NHS patients when the launch of the drug in England is confirmed by manufacturer Novo Nordisk. NICE has recommended use of semaglutide, alongside a reduced-calorie diet and increased physical activity, for adults who have at least one weight-related comorbidity and a body mass index (BMI) of at least 35kg/m2. This, along with a range of TikTok influencers claiming to be using the drug in the UK, has helped to create an increase in demand for Ozempic that has, in turn, put [sign up](https://onlinedoctor.boots.com/weight-loss/wegovy/) for information via the company’s website. The weight-loss drug semaglutide – to be launched as Wegovy – will be available for prescription via the NHS following the recommendation of its use by the National Institute for Health Care and Excellence (NICE). [The drug – which has not yet launched in the UK – is intended to help people reduce their weight by more than 10% when used with the support of a multidisciplinary team.](https://www.nursinginpractice.com/clinical/obesity-and-nutrition/government-programme-to-monitor-childhood-obesity-may-be-doing-more-harm-than-good/)

Trial results showed that participants taking semaglutide lost an average of 12% more of their body weight compared with placebo. Obesity. 08 March 2023.

“This is somewhat offset by the convenience of supply, particularly for those that may not engage with specialist healthcare provision. Responding to the recommendation that the drug can only be prescribed for a maximum of two years, le Roux highlighted that five-year data would soon be available via the ‘ “I believe there is no planned aligned funding from NHS England at the moment to help with redesign of weight management services and this is likely to be needed to ensure access meets the demands we expect.” Beba also highlighted imminent plans to provide the drug through high-street pharmacies and said that this had the potential to “drive inequalities in care”. NICE’s statement added that the drug would be available to NHS patients “soon” when the launch of the drug in England was confirmed by its manufacturer. [statement](https://www.nice.org.uk/news/article/nice-recommended-weight-loss-drug-to-be-made-available-in-specialist-nhs-services) dated 8 March 2023, Helen Knight, director of medicines evaluation at NICE, said: “Our committee has made specific recommendations to ensure it remains value for money for the taxpayer, and it can only be used for a maximum of two years.”

Senior diabetes doctors have told Sky News that patients are at risk of missing out on vital medication as private clinics stockpile semaglutide following a ...

Patients will only be able to take it for a two-year period. "It won't be available to everyone. The drug, he added, should only be used "in partnership with a clinical team ... "For me, this is literally going to change everything, because what it's doing is changing the physiological makeup of my body. Our committee has made specific recommendations to ensure it remains value for money for the taxpayer, and it can only be used for a maximum of two years." But Dr Stephen Lawrence, associate clinical professor at the University of Warwick, cautioned: "It is important to note, however, that this medication is not a quick fix or a replacement for following a healthy lifestyle, which includes regular physical activity and healthy eating." He said that while it is "fantastic" and a "positive break through" it isn't a solution that will "solve all the big problems". this isn't a drug to be used for people trying to look good on the beach". "It's changing the way I'm going to think around food, for instance, and then the way that my body thinks around food, and that's going to make such a huge impact on just general life. Lord Bethell, a former health minister, said the injection would give people the opportunity to "press the reset button and to work a different way to get their weight down" and address any health issues. "Obesity is a chronic long-term condition and it's a relapsing condition so you lose weight and you put it back on again and at the moment, there are very few treatment options for people living with obesity," she told Sky News. But the "pivotal moment" for weight loss has already been hit by supply chain issues and it is currently unclear whether the company that makes the jab, Novo Nordisk, will be able to adequately supply the NHS.